Your Memory Matters (www.yourmemorymatters.com) is a website for those with questions about early memory loss.

L-methylfolate

L-METHYLFOLATE IN CEREFOLIN®NAC OFFERS SUPERIOR HOMOCYSTEINE PROTECTION

L-methylfolate is directly involved in Hcy metabolism.

In a comparison of single dose 5mg L-methylfolate to 5mg folic acid, L-methylfolate was 3X more effective in decreasing plasma homocysteine.

Cerefolin®NAC provides your patients with the superior homocysteine effect of 5mg L-methylfolate.

The active ingredient in CerefolinNAC offers advanced homocysteine protection
Data on file

L-methylfolate in Cerefolin®NAC Offers Superior Bioavailability


SUPERIOR BIOAVAILABILITY
Data on file


Folic Acid Blocks Transport of L-methylfolate Across the Blood Brain Barrier

Folic acid hinders L-methylfolate transport across blood brain barrier (chart)
This illustration represents technical information presented in: Wu D and Pardridge WM. Blood-brain barrier transport of reduced folic acid. Pharmaceutical Research. 1999;16(3):415-419. Spector R and Lorenzo AV. Folate transport in the central nervous system. Am J Physiol. 1975;229(3):777-82.


2 out of 3 cognitively impaired patients may have a compromised ability to get folate into the brain

Patients with the MTHFR Polymorphism and elevated homocysteine are 6X more likely to develop progressive memory loss.1

2 out of 3 memory impaired patients have a compromised ability to get folate into the brain. 2


This illustration represents technical information presented in: Yoo J, Choi G, Kang S. Pathogenicity of Thermolabile Methylenetetrahydrofolate Reductase for Vascular Dementia. Artioscler Thromb Vasc Biol. August 2000;1921-1925.

L-methylfolate in Cerefolin®NAC is the only form of folate used by the brain


Metabolism of Folate
This chart represents technical information presented in: Refsum H, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Chemical Chemistry. 2004;50(1):3-32.

  1. Anello G, et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. NeuroReport. 2004;15(5):859-861.
  2. Yoo J, Choi G, Kang S. Pathogenicity of Thermolabile Methylenetetrahydrofolate Reductase for Vascular Dementia. Artioscler Thromb Vasc Biol. August 2000;1921-1925.